Karolinska Development Correlations
| KDEV Stock | SEK 1.06 0.03 2.91% |
The current 90-days correlation between Karolinska Development and Oncopeptides AB is -0.02 (i.e., Good diversification). The correlation of Karolinska Development is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Karolinska Development Correlation With Market
Significant diversification
The correlation between Karolinska Development AB and DJI is 0.05 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Karolinska Development AB and DJI in the same portfolio, assuming nothing else is changed.
Karolinska |
The ability to find closely correlated positions to Karolinska Development could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Karolinska Development when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Karolinska Development - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Karolinska Development AB to buy it.
Moving together with Karolinska Stock
Moving against Karolinska Stock
| 0.53 | SHB-B | Svenska Handelsbanken | PairCorr |
| 0.48 | ERIC-A | Telefonaktiebolaget | PairCorr |
| 0.42 | SHB-A | Svenska Handelsbanken | PairCorr |
Related Correlations Analysis
| 0.86 | -0.56 | 0.01 | -0.26 | ONCO | ||
| 0.86 | -0.69 | 0.39 | 0.0 | CANTA | ||
| -0.56 | -0.69 | -0.49 | -0.06 | BINV | ||
| 0.01 | 0.39 | -0.49 | 0.33 | MOB | ||
| -0.26 | 0.0 | -0.06 | 0.33 | BIOA-B | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Karolinska Stock performing well and Karolinska Development Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Karolinska Development's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ONCO | 2.10 | (0.55) | 0.00 | (1.43) | 0.00 | 3.83 | 34.67 | |||
| CANTA | 3.24 | (1.07) | 0.00 | (1.25) | 0.00 | 6.11 | 48.23 | |||
| BINV | 2.78 | 0.11 | 0.05 | 0.19 | 3.12 | 5.99 | 22.23 | |||
| MOB | 4.21 | (0.20) | 0.00 | 1.02 | 0.00 | 7.15 | 63.08 | |||
| BIOA-B | 2.73 | 0.40 | 0.07 | (0.62) | 2.87 | 6.39 | 39.02 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Karolinska Development without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Backtesting Now
Portfolio BacktestingAvoid under-diversification and over-optimization by backtesting your portfolios |
| All Next | Launch Module |
Karolinska Development Corporate Management
Elected by the shareholders, the Karolinska Development's board of directors comprises two types of representatives: Karolinska Development inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Karolinska. The board's role is to monitor Karolinska Development's management team and ensure that shareholders' interests are well served. Karolinska Development's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Karolinska Development's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Per Aniansson | Investment Director | Profile | |
| Eva Montgomerie | Head of Accounting | Profile | |
| Johan Dighed | Chief CEO | Profile | |
| Linda Spahiu | Investment Mang | Profile | |
| Hans Toll | Chief Officer | Profile | |
| Viktor MD | Chief Officer | Profile |